Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

MLA

Aplenc R, et al. “Safety and Efficacy of Gemtuzumab Ozogamicin in Combination with Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report from the Children’s Oncology Group.” Journal of Clinical Oncology, vol. 26, no. 14, May 2008, pp. 2390–3295. EBSCOhost, https://doi.org/10.1200/JCO.2007.13.0096.

APA

Aplenc R, Alonzo TA, Gerbing RB, Lange BJ, Hurwitz CA, Wells RJ, Bernstein I, Buckley P, Krimmel K, Smith FO, Sievers EL, Arceci RJ, Children’s Oncology Group, Aplenc, R., Alonzo, T. A., Gerbing, R. B., Lange, B. J., Hurwitz, C. A., Wells, R. J., & Bernstein, I. (2008). Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group. Journal of Clinical Oncology, 26(14), 2390–3295. https://doi.org/10.1200/JCO.2007.13.0096

Chicago

Aplenc R, Alonzo TA, Gerbing RB, Lange BJ, Hurwitz CA, Wells RJ, Bernstein I, et al. 2008. “Safety and Efficacy of Gemtuzumab Ozogamicin in Combination with Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report from the Children’s Oncology Group.” Journal of Clinical Oncology 26 (14): 2390–3295. doi:10.1200/JCO.2007.13.0096.